HaloVerse · Advancing Europe's Next Generations on the Path to Sustainability – Expanding the Universe of Enzymatic Halogenation Chemistry
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2026-01-01 → 2030-12-31
- Финансиране от ЕС
- 3 869 143 €
- Участници
- 21
- Схема
- HORIZON-TMA-MSCA-DN-JD
Линиите свързват координатора с партньорите.
Накратко на български
Ензимната халогенация изследва използването на биологични катализатори за създаване на лекарства и земеделски химикали. Това помага за намаляване на замърсяването на околната среда и по-ефективно използване на енергията при химичните процеси.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
The mission of the HALOVERSE double doctorates PhD programme is to train 13 PhD students in a synergistic multidisciplinary environment to lead Europe's next generations towards sustainability in halogenation, a highly polluting chemical process. Enzyme catalysis contributes to sustainability through efficient use of natural resources and energy, minimising environmental impact and supporting the European Green Deal, the MSCA Green Charter and the UN SDGs. HALOVERSE will develop powerful enzymatic systems for selective halogenation to revolutionise 21st century chemistry. It aims to overcome the limitations of enzymatic halogenation by discovering and engineering biocatalysts with broad catalytic scope, substrate diversity and robustness, and by developing new process strategies for the functionalisation of complex molecules. HALOVERSE will bridge academic proof-of-concept knowledge with industrial applications by integrating the predictive power of computational biology and novel continuous process strategies on three classes of halogenases to produce versatile pharmaceuticals, fine- and agrochemicals. The scientific approach of the double degree programme will provide in-depth training in complementary disciplines, combining advanced enzymology and computational biology with the engineering challenges posed by halogenases in industrial settings. Industrial partners will lead innovation, scale up commercially relevant processes focusing on continuous synthesis and contribute to the training programme, ensuring technology transfer and development strategies, both career and product oriented. HALOVERSE will ensure European leadership in industrial biotechnology, paving the way for bio-based materials and products with a low environmental footprint, preventing and mitigating pollution. 12 non-academic partners and 10 academic institutions provide a synergistic environment and offer 13 PhD students excellent employability profiles in the European biotechnology sector.
Оригинален текст от CORDIS (на английски).
Участници
- RIJKSUNIVERSITEIT GRONINGEN · GroningenКоординаторНидерландия
- ASTRAZENECA AB · SodertaeljeШвеция
- Aminoverse B.V. · NuthНидерландия
- BASF SE · Ludwigshafen Am RheinГермания
- BAYER AKTIENGESELLSCHAFT · LeverkusenГермания
- BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AG · ZwingenbergГермания
- Enzyan Biocatalysis GmbH · GrazАвстрия
- Exazyme GmbH · BerlinГермания
- INSEIT AG · BernШвейцария
- NOVA-INSTITUT FUR POLITISCHE UND OKOLOGISCHE INNOVATION GMBH · HurthГермания
- PANEPISTIMIO KRITIS · RETHIMNOГърция
- PROZOMIX LIMITED · HaltwhistleОбединеното кралство
- RUHR-UNIVERSITAET BOCHUM · BochumГермания
- SYNGENTA LIMITED · BRACKNELL BERKSHIREОбединеното кралство
- TECHNISCHE UNIVERSITEIT DELFT · DelftНидерландия
- UNIVERSITA DEGLI STUDI DI MILANO · MilanoИталия
- UNIVERSITA DEGLI STUDI DI PAVIA · PaviaИталия
- UNIVERSITAET BERN · BernШвейцария
- UNIVERSITAT DE GIRONA · GironaИспания
- UNIVERSITY OF STUTTGART · StuttgartГермания
- ZYMVOL BIOMODELING SL · BarcelonaИспания
Връзки
Данни: CORDIS, © Европейски съюз